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Abstract
Incidence of carbapenem-resistant Acinetobacter baumannii is rising in several parts of the world. In Africa, data concerning
this species and its resistance to carbapenems are limited. The objective of the present study was to identify the presence of
A. baumannii carbapenem-resistant encoding genes in natural reservoirs in Senegal, where antibiotic pressure is believed to
be low. From October 2010 to January 2011, 354 human head lice, 717 human fecal samples and 118 animal fecal samples
were screened for the presence of A. baumannii by real time PCR targeting blaOXA51-like gene. For all samples positive for A.
baumannii, the carbapenemase-hydrolysing oxacillinases blaOXA23-like and blaOXA24-like were searched for and sequenced,
and the isolates harbouring an oxacillinase were genotyped using PCR amplification and sequencing of recA gene. The
presence of A. baumannii was detected in 4.0% of the head lice, in 5.4% of the human stool samples and in 5.1% of the
animal stool samples tested. No blaOXA24 gene was detected but six fecal samples and three lice were positive for blaOXA23-
like gene. The blaOXA23-like gene isolated in lice was likely a new oxacillinase sequence. Finally, the A. baumannii detected in
stools were all of recA genotype 3 and those detected in lice, of recA genotype 4. This study shows for the first time
a reservoir of blaOXA23-like-positive gene in human head lice and stool samples in Senegal.
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Introduction
Acinetobacter baumannii is a Gram-negative coccobacillus that has
emerged over the last few decades as a cause of both healthcare-
associated and community-acquired infections [1,2]. This bacte-
rium is an important nosocomial pathogen of critically ill patients
that can cause a wide range of infections, including ventilator-
associated pneumonia, bloodstream infections, wound infections
and nosocomial meningitis [1,3,4]. While A. baumannii is isolated
from patients and hospital environment sources during outbreaks,
the reservoir outside hospitals is not well delineated. This species
can be isolated from human skin (between 0.5% and 3%
according to the study), animal feces, water, soil or vegetables
[5–8], but taken together, current data indicate that occurrence of
A. baumannii in the environment is not well characterized [9]. The
bacterium has also been isolated from human head and body lice
as previously described [10].
Acquired resistance of A. baumannii to carbapenems has
increasingly been reported all over the world during the last
decade [2,11,12]. Until recently, antibiotic consumption has been
pointed out as principal causative agent in acquisition of resistance
genes [13]. However, this concept has been challenged since it has
been discovered in 2011 a highly diverse collection of genes
encoding resistance to beta-lactam, tetracycline and glycopeptide
antibiotics in an authenticated ancient DNA from 30,000-year-old
Beringian permafrost sediments [14]. This discovery has shown
that there are reservoirs of resistance determinants that can be
mobilized into the microbial community. Thus, although antibi-
otic resistance has long been considered as a modern phenome-
non, it predates the concept of selective antibiotic pressure due to
clinical antibiotic usage [14,15].
To eventually confirm this paradigm, the objective of our study
was to detect and to identify the presence of A. baumannii and
carbapenem resistant encoding genes in natural environments in
Senegal, i.e. in head lice and feces from people and pets living in
different rural areas, where antibiotic pressure is believed to be
low.
Results
Detection of A. baumannii
Head lice. From October 2010 to January 2011, 354 head
lice collected from 128 women and girls (10 adults and 118
children) were analyzed and included in this study. A geographical
repartition of women whose head lice were collected is presented
in Figure 1. All the head lice collected were black. A. baumannii was
detected by PCR targeting blaOXA51-like gene in 14 head lice (4.0%)
collected from 6 women (4.0%). Among these positive lice, 5 were
collected in Keur Massar (12.5% of the lice collected in Keur
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39495Massar), 4 in Rufisque (7.5%), 3 in Malika (5.3%), and 2 in Dielmo
(10.0%).
Human stool samples. The number of human stool samples
tested by PCR targeting blaOXA51-like gene for the presence of A.
baumannii was 150 in 2008, 496 in 2009, 20 in 2010 and 51 in 2011
(Table 1). Among them, 39 were positive by PCR for A. baumannii
(5.4%): 9 in 2008, 27 in 2009, 1 in 2010 and 2 in 2011. The
majority of the positive stool samples were collected in Dielmo (29
samples). For 2011, cultivation of the 51 fresh stool specimens
allowed identification of A. baumannii by MALDI-TOF MS in two
samples, those who were positive by PCR for A. baumannii.
Antibiotic susceptibility testing was performed, and both strains
were found to be resistant to imipenem (MICs.8 confirmed using
the E test). The strains were isolated from the stools of a man and
a woman living in Mbao. These two isolates were also resistant to
all of the other antibiotics tested, except colistin and rifampin.
Animal stool samples. The presence of A. baumannii was
searched by cultivation in stool samples from 11 donkeys, 22 cows,
9 ducks, 19 goats, 42 chickens, 8 sheep, 6 pigeons and one dog.
The bacterium was isolated in seven samples (3 goats, 1 duck, 1
pigeon, 1 donkey and 1 chicken).
Detection of the Carbapenemase-hydrolyzing
Oxacillinases
All of the blaOXA-51-like-positive samples (14 head lice, 39 human
and 7 animal stool samples) were checked for the presence of
carbapenemase-encoding genes using PCR methods. No sample
was positive for the blaOXA24-like gene, but PCR targeting blaOXA23-
like-gene was positive for 3 head lice and in 6 human stools. No
animal stool sample was positive for either blaOXA-like gene. The
head lice came all from Rufisque Ouest, and the stool samples
were collected in Ndiop (four samples) and Mbao (two samples).
The blaOXA23-like gene from these samples was sequenced, and the
nucleotidic sequences were compared to the GenBank database
using BLASTN. Of the six stool samples, all presented 100% of
similarity with GenBank accession no. AJ132105. Of the three lice
Figure 1. Head lice collection in Senegal. A: Head lice collection areas (Dakar, Kaolack, Sine-Saloum, Dielmo and Ndiop). B: Head lice collection
sites in the suburbs of the Dakar region. Diamonds: number of lice positive for A. baumannii; green diamonds: A. baumannii negative for the blaOXA23-
like gene; red diamonds: A. baumannii positive for the blaOXA23-like gene.
doi:10.1371/journal.pone.0039495.g001
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were obtained that were 100% identical to each other and
presented 100% of similarity with blaOXA23-like sequences recently
reported from groundwater samples coming from the Katmandu
Valley of Nepal (GenBank accession no. AB636089). The partial
translated protein sequences showed four differences in amino acid
composition at positions 4, 41, 44 and 48 (Figure 2), leading to
a probable new variant of blaOXA23-like gene closely related to
blaOXA134 gene from A. radioresistens (Figure 3). These three
sequences have been deposited in Genbank under the submission
ID 1538144. Unfortunately, we were not able to obtain the full
sequence of this gene despite several attempts. The blaOXA51-like
gene from the two carbapanem-resistant A. baumannii isolated by
culture in stools were also sequenced and are also presented in
Figure 3. Finally, PFGE and southern blot analysis of the blaOXA23-
like gene found in the two A. baumannii strains isolated in the stool
samples likely suggest that the gene was chromosomally encoded
(Figure 4).
A. baumannii recA Genotyping
The nine samples positive for the blaOXA23-like gene were also
sequenced for recA gene. Amplifying the recA gene allowed
unambiguous determination of the sequence of a 336-base pair
fragment. Concerning the three lice samples, all were of genotype
4 (GenBank accession no. AY274829)(11). The stool samples were
all of genotype 3 (GenBank accession no. AY274828). Some
samples negative for the blaOXA23-like gene were also sequenced for
the recA gene and results showed that they were mostly of genotype
1 (GenBank accession no. AY274826).
Discussion
In our work, we have shown that 4.0% of the head lice studied
were positive for A. baumannii (14/354). The head lice being
transported in alcohol, direct identification by culture could not be
performed. Thus, the bacteria were detected by molecular
methods only from head lice extracts with primers specific for
blaOXA-51-like gene. A. baumannii has previously been found in body
lice collected from different European countries, from sub-
Saharan African countries and from the South American
continent [10], but the presence of the bacterium in lice in
Senegal has not been highlighted. We have also shown that 5.4%
of the human stool samples and 6.0% of the animal stool samples
studied were positive for A. baumannii. Presence of A. baumannii in
stool samples has already been shown in individuals from the
community in European countries [8] but to our knowledge,
environmental studies in Africa searching for the bacteria have
never been performed. Our study confirmed that A. baumannii is
not exclusively a hospital pathogen but also a nationwide human
and animal colonizer.
Detection of carbapenemase encoding genes was performed on
all the blaOXA-51 like gene positive samples and results showed that
21.4% of the head lice (3/14) harbored a blaOXA-23-like gene
sequence. We believe that these sequences belong to A. baumannii
species because, to the best of our knowledge, only A. baumannii
species has been detected in human body lice to date. Sequencing
of this gene allowed discovering a putative new variant but
unfortunately we were unable to obtain the full sequence of this
gene. Interestingly, our sequence was 100% identical to blaOXA23-
like partial sequences found recently by Tanaka et al.i n
groundwater samples coming from the Katmandu Valley of
Nepal, showing presence of multi-drug resistant Acinetobacter in
different environments in the world [16]. These sequences are
closely related to blaOXA134 gene from A. radioresistens (Figure 3).
Carbapenem-resistance encoding gene sequences have never been
detected previously in human lice. Until now, the A. baumannii
isolates detected in human lice were remarkably susceptible to
antibiotics, particularly to carbapenems [10], as shown by the
sequenced SDF strain isolated from a human body louse. Analysis
of its genome showed a remarkably susceptible strain that
harbored several hundred of Insertion Sequence elements [17]
that might play a role in the acquisition of carbapenem-resistant
genes in A. baumannii. Thus, it would be necessary, in future
Table 1. Repartition of stool samples and A. baumannii-positive stool samples.









Year 2008 : 150 ss
Dielmo: 73 ss 71/79/0 150/0/0 9 (Dielmo) 0
Ndiop: 77 ss
Year 2009 : 496 ss
Dielmo: 232 ss
Ndiop: 258 ss 222/256/18 246/222/28 27 (Dielmo: 20; Ndiop: 7) 4 (Ndiop)
Dakar: 4 ss
Nhiakar: 2 ss
Year 2010 : 20 ss
Dielmo: 20 ss 11/9/0 11/6/3 1 (Dielmo) 0
Year 2011 : 51 ss
Mbao: 28 ss
Dominique-Pikine: 7 ss 28/23/0 22/29/0 2 (Mbao) 2 (Mbao)
Roi Baudoin: 6 ss
IHS: 4 ss
Saint Martin: 6 ss
doi:10.1371/journal.pone.0039495.t001
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to fully characterize this carbapenemase encoding gene.
Besides, our study was the first to show the presence of
carbapenem-resistant A. baumannii isolates in human stool samples
in Senegal. Carbapenem resistance, which has been detected by
antimicrobial susceptibility testing, was associated with resistance
to all of the beta-lactams and to most of the antibiotics tested.
Resistance to carbapenems has been characterized at the
molecular level with specific primers targeting two oxacillinase
genes and here, blaOXA-23-like was detected. Multidrug-resistant
(MDR) A. baumannii strains producing oxacillinase enzymes have
been reported worldwide, especially in nosocomial outbreaks
[1,2,18,19]. These facts have been evidenced by the large number
of studies published [1,2,20]. However, concerning the epidemi-
ology of MDR A. baumannii in African countries, only a few studies
have been performed. MDR strains have been isolated in Tunisia
[21], Algeria [19,22,23], Namibia and South Africa [24]. What
was intriguing in our study was that carbapenemase encoding
genes were detected in environmental samples where antibiotic
pressure was low. Some explanation might be brought by D’Costa
et al., who recently discovered reservoirs of resistance determinants
in environments like permafrost sediments that were free from
antibiotic contamination [14], showing that antibiotic resistance
predates the concept of selective antibiotic pressure due to clinical
antibiotic usage. It has also been shown that soil-dwelling bacteria
produced and encountered a myriad of antibiotics, and that they
are a reservoir of resistance determinants that can be mobilized
into the microbial community [25]. Although there was no doubt
that blaOXA23 gene was present in A. baumannii species for the two
human stool isolates in our study, we could not exclude the
possibility that samples only analyzed by PCR methods that were
positive for blaOXA51 and blaOXA23 could be due to the
combination of A. baumannii with another Acinetobacter spp.
harboring blaOXA23. Although blaOXA-23-like gene was likely
transferred in environment from a reservoir that is unknown
here, gene transfer from the environmental bacterium Acinetobacter
radioresistens has been previously described by Poirel et al. [26].
More recently, the presence of the blaOXA23-like gene has also been
detected in Acinetobacter genomospecies 15TU isolates found in
rectal samples collected from cattles in France, suggesting potential
gene exchanges [27]. Our suppositions are supported by the fact
that lateral gene-transfer are common and can be important
Figure 2. CLUSTAL W2 nucleotidic alignment of the three blaOXA23-like-positive A. baumannii found in lice (indicated louse 1 to 3) and
of the six blaOXA23-like-positive A. baumannii found in human stool samples (indicated stool 1 to 6). The blaOXA23-like gene AJ132105 was
taken as reference.
doi:10.1371/journal.pone.0039495.g002
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question on the presence of genetic mobile elements in A.
baumannii, that have shown to play a key role in regulatory
changes [29].
Finally, the recA genotypes of the A. baumannii found in the
blaOXA23-like –containing samples were limited to two clones. One
clone was detected only in lice that were collected in Rufisque (east
of Dakar), and the other one was detected only in stools that were
collected in Ndiop (South of Dakar) and Mbao (east of Dakar, near
Rufisque). Thus, A. baumannii genotypes were specific to the sample
origin and not distributed geographically.
In summary, our study showed the presence of a reservoir of A.
baumannii carbapenem-resistant isolates in human stools collected
in Senegal, in places where it is unlikely that they have been
selected by antibiotic prescriptions. Finally, our results question the
breadth of A. baumannii reservoirs and the cause of the carbapenem
resistance beyond antibiotic pressure.
Materials and Methods
A part of this study concerns the Dielmo project, a longitudinal
prospective study initiated in 1990 for long-term investigation of
host-parasite relationships [30,31].
Sample Collection
Head lice were collected from October 2010 to January 2011,
from women with no clinical symptoms from different locations in
Senegal (Figure 1). Lice collected in Ndiop were preserved in
alcohol; the others were kept in dry tubes. All of them were
transferred to Marseille (France) at room temperature. The human
stool samples included in this study were collected from 2008 to
2010 in Dielmo and Ndiop, Senegal, from healthy persons, as
previously described [32], and mixed with 2.5 mL of absolute
ethanol for storage and transportation to Marseille at room
temperature. In 2011, 51 diarrheal stool samples were also
collected in Dakar (Senegal) and cultivated on Drigalski and sheep
blood agar media. In addition, free stool samples were collected
immediately after defecation to decrease the risk of contamination
from soil by local farmers on their own domestic and wild animals
in the area of Dielmo and Ndiop and cultivated. No experimen-
tation was done on these animals. Bacterial identification at the
species level was performed on each colony obtained on the
culture media using the Matrix-assisted Laser Desorption Time-of-
Flight Mass Spectrometry (MALDI-TOF MS) (Microflex, Bruker
Daltonics) with the flex control software (Bruker Daltonics). A
score value .1.9 was considered positive for identification at the
species level, as previously reported [33].
Figure 3. Carbapenemase-hydrolysing oxacillinases phylogenetic tree using neighbour-joining method. *, partial blaOXA-23
sequences found in Uncultured Acinetobacter isolated from groundwater collected from deep tube well in Nepal.
doi:10.1371/journal.pone.0039495.g003
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For the A. baumannii strains isolated in human and animal stool
samples in 2011, antibiotic susceptibility testing was performed by
the disc diffusion method using a panel of 14 different antibiotics
including ticarcillin-clavulanic acid, piperacillin-tazobactam, cef-
tazidime, imipenem, ciprofloxacin, amikacin, gentamicin, tobra-
mycin, sulfamethoxazole-trimethoprim, colistin and rifampicin
[18]. Susceptibility breakpoints used were those recommended by
EUCAST (www.eucast.org). According to EUCAST breakpoints,
an isolate is considered resistant or susceptible to imipenem with
inhibition diameters ,17 mm and $23 mm, respectively. For
isolates with diameters ,17 mm, Minimum Inhibitory Concen-
trations (MICs) were determined using the E test method (AB
Biodisk, Solna, Sweden), and resistance was defined as isolates
with MIC against imipenem .8 mg/L.
Molecular Detection of Carbapenemase-hydrolyzing
Oxacillinases
Genomic DNA was extracted from bacterial colonies identified
as A. baumannii by MALDI-TOF MS, as described above.
Concerning the lice, each was previously rinsed twice in sterile
water for 15 minutes. Total genomic DNA from each half louse
and all stool samples collected was extracted using the BioRobot
MDx workstation (QIAGEN, Hilden, Germany) in accordance
with the manufacturer’s recommendations and protocols. The
detection of A. baumannii was determined by screening the samples
(lice and stool) with a real-time PCR assay targeting the blaOXA51-
like gene (Table 2). Amplification was performed using thermo-
cycler conditions as follows: an initial denaturation step at 95uC
for 15 min followed by 40 cycles of denaturation at 95uC for
30 sec and extension at 60uC for 1 min. Negative and positive
controls were included in each assay. For all the samples positive
for blaOXA51-like gene, molecular detection and sequencing of the
carbapenemase-encoding genes blaOXA23-like and blaOXA24-like, the
two most common carbapenemase-encoding genes in A. baumannii,
was performed by PCR. The presence of blaOXA58 gene was not
investigated in this study. The conditions used for detection are as
follows: an initial denaturation step at 95uC for 15 min followed by
40 cycles of denaturation at 95uC for 30 sec, hybridization at 57uC
for 30 sec and extension at 72uC for 1 min, and a final extension
at 72uC for 10 min. (Table 2). Finally, the blaOXA51-like gene was
sequenced for carbapenem-resistant A. baumannii isolated by
cultivation.
A. baumannii recA Genotyping
For samples positive for carbapenemase-hydrolyzing oxacilli-
nases, the recA gene was amplified and sequenced using specific
primers as previously described [10] (Table 2). Some negative
samples were also selected for recA genotype determination.
Genotypes were determined by comparing recA sequences with the
genotypes deposited in the GenBank database.
Carbapenemase-encoding Genes Analysis by PFGE and
Hybridization
A. baumannii genomic DNA plugs were performed and
equilibrated in 0.56TBE (50 mM Tris, 50 mM boric acid,
1 mM EDTA). Each agarose block as well as molecular weight
markers (Low Range PFG Marker and Lambda Ladder PFG
Marker – Biolabs, New England) were placed in the well of a 1%
PFGE agarose gel (Sigma). The pulsed field gel separation was
made on a CHEF –DR II apparatus (Bio-Rad Laboratories, Inc)
with pulses ranging from 2 to 20 seconds at a voltage of 5 V/cm
and switch angle of 120u for 22 hours at 14uC. Gels were stained
with ethidium bromide and analyzed using a Gel-Doc 2000 system
(Bio-Rad Laboratories) and used to prepare Southern blots. The
gel was transferred onto Hybond N+ (GE Helathcare) with the
vacuum blotter (model 785, Bio-Rad) and UV cross-linked for
2 min. The blots were then hybridized against the Oxa-23 DIG-
labeled probe (Table 2) as recommended by the manufacturer
(DIG-System, Roche Diagnostics) except that detection of the
hybridized probe was performed using a horseradish peroxidase-
conjugated monoclonal Mouse Anti-Digoxin (Jackson Immunor-
esearch, 1:20 000). After washings, blots were revealed by
chemiluminescence assays (ECL, GE Healthcare). The resulting
signal was detected on Hyperfilm
TM ECL (GE Healthcare) by




Informed verbal consents were obtained from all the partici-
pants involved in our study. This study was approved (Agreement
#11-010), by the Ethic Committee of the Institute Fe ´de ´ratif de
Recherche 48, Marseilles, France since this study was a non-
interventional epidemiological research study as a part of the
Figure 4. PFGE and hybridization analysis. A. Pulsed field gel
electrophoresis (PFGE) profiles obtained for the two Acinetobacter
baumannii strains isolated from the stool samples from two patients
living in Mbao. The Low Range PFG Marker (LRM) was used as molecular
weight marker. B. Southern blot profile obtained for the two
Acinetobacter baumannii strains isolated from the stool samples from
two patients living in Mbao after hybridization against the blaOXA-23 like
DIG-labeled probe. Arrows indicate putative plasmids.
doi:10.1371/journal.pone.0039495.g004
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stool samples were collected from soil by local farmers on their
own domestic and wild animals in the area of Dielmo and Ndiop
and cultivated and no experimentation was done on these animals.
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